BACKGROUND: Late rectal injury is a common side effect of external beam radiotherapy for prostate cancer.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
AIM: The aim of this study was to evaluate what total dose may be safely delivered for prostate patients for 3DCRT and IMRT techniques and the CTV-PTV margin.
MATERIALS AND METHODS: 3DCRT and IMRT plans were prepared for 12 patients. For each patient PTV was defined with CTV-PTV margins of 0.4, 0.6, …, 1.0 cm, and total doses of 70, 72, …, 80 Gy, with 2 Gy dose fraction. NTCP values for the rectum were calculated using the Lyman model. Both techniques were compared in terms of population mean DVH.
RESULTS: Significantly smaller NTCPs for IMRT were obtained. For both techniques diminishing the margin CTV-PTV of 2 mm leads to decreasing the NTCP of about 0.03. For total dose of 80 Gy the NTCP was smaller than 10% for the 4 mm margin only. The QUANTEC dose volume constraints were more frequently fulfilled for the IMRT technique than for the 3DCRT technique.
CONCLUSIONS: The IMRT technique is safer for prostate patients than the 3DCRT. If very high total doses are applied the CTV-PTV margin of 0.4 cm and the IMRT technique should be used. If the CTV-PTV margin of 0.6 cm is applied, the NTCP is smaller than 10% for the 3DCRT and IMRT techniques for the total doses smaller than 74 Gy and 78 Gy, respectively.
Kukołowicz P, Kukołowicz H, Tyburska I. Are you the author?
The Maria Skłodowska - Curie Memorial Cancer Center and Institute of Oncology, Medical Physics Department, Warsaw, Poland.
Reference: Rep Pract Oncol Radiother. 2015 May-Jun;20(3):198-203.